股票 › BMRN
拜玛林制药 BMRN
美股市值排名 #1377
$56.03 −$0.09 (-0.16%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $56.03 0.00%
开盘$55.25
昨收$56.12
当日区间$55.00 – $56.08
成交量2.73M
市值$10.85B
市盈率（TTM）–
股息率–
BMRN 相关新闻
匹配 Biomarin Pharmaceutical 或代码 BMRN 的头条新闻，按最新排序。
- J.P. Morgan Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Announces Target Price $86
- Piper Sandler Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Raises Target Price to $90 正面
- Cantor Fitzgerald Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Raises Target Price to $86 正面
- Guggenheim Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Cuts Target Price to $86 负面
- BMO Capital Upgrades Biomarin Pharmaceutical(BMRN.US) to Buy Rating, Raises Target Price to $97 正面
- Morgan Stanley Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $124
- Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Plenge Robert M
- Citi Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating
- Biomarin Pharmaceutical | 8-K: Current report
- Wells Fargo Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $80
- A Quick Look at Today's Ratings for Biomarin Pharmaceutical(BMRN.US), With a Forecast Between $70 to $124
- A Quick Look at Today's Ratings for Biomarin Pharmaceutical(BMRN.US), With a Forecast Between $62 to $124
- Stifel Maintains Biomarin Pharmaceutical(BMRN.US) With Hold Rating, Maintains Target Price $70
- Piper Sandler Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $88
- TD Cowen Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $120
暂无评论——快来第一个聊聊 BMRN。
登录后参与讨论。